Jurnalul Român de Psihoterapie Integrativă

Latest Science News -- ScienceDaily

Breaking science news and articles on global warming, extrasolar planets, stem cells, bird flu, autism, nanotechnology, dinosaurs, evolution -- the latest discoveries in astronomy, anthropology, biology, chemistry, climate and environment, computers, engineering, health and medicine, math, physics, psychology, technology, and more -- from the world's leading universities and research organizations.
Latest Science News -- ScienceDaily
  1. Short-term use of IV devices is common -- and risky -- study shows
    Many hospital patients get medicine or nutrition delivered straight into their bloodstream through a tiny device called a PICC. In just a decade, it's become the go-to device for intravenous care. But a new study finds that one in every four times a PICC gets inserted, the patient didn't need it long enough to justify the risks it can pose. And nearly one in ten of those patients suffered a complication linked to the device.
  2. Young children use physics, not previous rewards, to learn about tools
    Children as young as seven apply basic laws of physics to problem-solving, rather than learning from what has previously been rewarded, suggests new research.
  3. Metalens combined with an artificial muscle
    Inspired by the human eye, researchers have developed an adaptive metalens that is essentially a flat, electronically controlled artificial eye. The adaptive metalens simultaneously controls for three of the major contributors to blurry images: focus, astigmatism, and image shift.
  4. Charging ahead to higher energy batteries
    Researchers have developed a new way to improve lithium ion battery efficiency. Through the growth of a cubic crystal layer, the scientists have created a thin and dense connecting layer between the electrodes of the battery.
  5. Molecular Trojan horse delivers chemotherapeutic drug to cancer cells
    Researchers have discovered a way for chemotherapy drug paclitaxel to target migrating, or circulating, cancer cells, which are responsible for the development of tumor metastases. Until now, paclitaxel has only been used to target rapidly dividing cancer cells. The team was successful in getting the drug to piggyback on 123B9, an agent they devised to target an oncogene called EphA2.

Dacă faci o greșeală, recunoaște-o. Orice încercare de a o ascunde se va întoarce în cele din urmă împotriva ta. La un moment dat pacientul va simți că nu ești sincer și actul terapeutic va suferi. Mai mult, admiterea deschisă a greșelii este un model bun pentru pacienți și un semn în plus al importanței care o au pentru tine.

Irvin D.Yalom, M.D. Darul Psihoterapiei

UA-45651202-1